Kayser Robert Harvey 4
4 · STELLAR PHARMACEUTICALS INC · Filed Apr 7, 2009
Insider Transaction Report
Form 4
Kayser Robert Harvey
Director
Transactions
- Expiration
Stock Option (right to buy)
2009-04-07$1.66/sh−25,000$41,500→ 25,000 totalExercise: $1.66From: 2006-11-11Exp: 2008-05-12→ Common Shares (25,000 underlying) - Expiration
Stock Option (right to buy)
2008-12-31$0.91/sh−25,000$22,750→ 0 totalExercise: $0.91From: 2006-03-31Exp: 2008-12-31→ Common Shares (25,000 underlying)
Footnotes (1)
- [F1]Options vested at 1/6th quarterly as follows: 4,1667 on each of 03/31/2006, 06/30/2006,09/30/2006,12/31/2006 and 4,166 on each of 03/31/2007 and 06/30/2007